
Global Genomic Testing in Cancer Market Growth (Status and Outlook) 2024-2030
Description
Global Genomic Testing in Cancer Market Growth (Status and Outlook) 2024-2030
According to this study, the global Genomic Testing in Cancer market size will reach US$ million by 2030.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomic Testing in Cancer market by product type, application, key players and key regions and countries.
Segmentation by product type:
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Segmentation by Application:
General Hospitals
Specialty Clinics
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
88 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Genomic Testing in Cancer Key Players
- 4 Genomic Testing in Cancer by Regions
- 5 United States
- 6 Europe
- 7 China
- 8 Rest of World
- 9 Market Drivers, Challenges and Trends
- 10 Key Investors in Genomic Testing in Cancer
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.